Zhi Peng

Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results

Changsong Qi, Jifang Gong, Jian Li et al. · Nature Medicine · 2022 · 571 citations · Full text

Medicine, Oncology, Pharmacokinetics +17

The Gut Microbiome Is Associated with Clinical Response to Anti–PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer

Zhi Peng, Siyuan Cheng, Yan Kou et al. · Cancer Immunology Research · 2020 · 351 citations

Life Sciences, Microbiology, Oncology +17

Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study

Zhi Peng, Tianshu Liu, Jia Wei et al. · Cancer Communications · 2021 · 202 citations · Full text

Medicine, Oncology, Pharmacology +16

Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results

Changsong Qi, Chang Liu, Jifang Gong et al. · Nature Medicine · 2024 · 178 citations

Medicine, Immunology, Oncology +13

Phase I study of the recombinant humanized anti-HER2 monoclonal antibody–MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors

Yingying Xu, Yakun Wang, Jifang Gong et al. · Gastric Cancer · 2021 · 149 citations · Full text

Medicine, Oncology, Pharmacology +17